Pharmacological effects of dopaminergic drugs on in vivo binding of [99mTc]TRODAT-1 to the central dopamine transporters in rats

European Journal of Nuclear Medicine

Volumn 25, Issue 1, 1998, Pages 31-39

  Dresel, Stefan H J ^a   Kung, Mei Ping ^a   Plössl, Karl ^a   Meegalla, Sanath K ^a   Kung, Hank F ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Brain; Dopamine transporter ligands; In vivo binding; Parkinson's disease; Single photon emission tomography

Indexed keywords

3BETA (4 FLUOROPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; DEXAMPHETAMINE; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; DOPAMINE TRANSPORTER; LACTONE DERIVATIVE; LEVODOPA; METHYLPHENIDATE; METIROSINE; TECHNETIUM 99M; TROPANE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING SITE; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; DOSE RESPONSE; DRUG BINDING; IMAGING; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; RAT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ANIMALS; CARRIER PROTEINS; DOPAMINE; DOPAMINE AGENTS; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; ORGANOTECHNETIUM COMPOUNDS; PROTEIN BINDING; RADIOPHARMACEUTICALS; RATS; RATS, SPRAGUE-DAWLEY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TROPANES;

EID: 0031951078     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050191     Document Type: Article

References (73)

1. Guttman M. Dopamine receptors in Parkinson's disease. Neurol Clin 1992; 10: 377-386.
2. Seeman P. Dopamine receptors and the dopamine hypothesis of schizophrenia [review]. Synapse 1987; 1: 133-152.
3. Reith MEA, ed. Neurotransmitter transporters: structure, function, and regulation, Totowa, N.J.: Humana Press, 1997.
4. 125I]RTI-55 to dopamine transporters: pharmacology and regional distribution with autoradiography. Synapse 1992; 12: 37-46.
5. 3H]cocaine in striatum and its relationship to the dopamine transporter. Membr Biochem 1987; 7: 87-106.
6. 3H]nomifensine to striatal membranes. Biochem Pharmocol 1985; 34: 1137-1144.
7. 3H]GBR-12935 binding to the dopamine transporter is decreased in the caudate nucleus in Parkinson's disease. J Neurochem 1987; 49: 617-621.
8. 3H]2β-carbomethoxy-3β-(4-fluorophenyl) tropane. Mol Pharmacol 1989; 36: 518-524.
9. 3H]WIN 35,065-2: a ligand for cocaine receptor in striatum. J Neurochem 1990; 55: 1556-1562.
10. Ritz MC, Cone EJ, Kuhar MJ. Cocaine inhibition of ligand binding at dopamine, norepinephrine and serotonin transporters: a structure-activity study. Life Sci 1990; 46:635-645.
11. Frost JJ, Rosier AM, Reich SG, Smith JS, Ehlers MD, Snyder SH, Raven HT, Dannals RF. PET imaging of dopamine reuptake sites in Parkinson's disease by C-11 WIN35,428 and PET. J Nucl Med 1993; 34.
12. 11C]WIN35,428. Synapse 1993; 15: 130-142.
13. Meltzer PC, Liang AY, Brownell A-L, Elmaleh DR, Madras BK. Substituted 3-phenyltropane analogs of cocaine: synthesis, inhibition of binding at cocaine recognition sites, and positron emission tomography imaging. J Med Chem 1993; 36: 855-862.
14. 18F]Fluoro-L-m-tyrosine: an L-2,4-dihydroxyphenylalanine analog for probing presynaptic dopaminergic function with positron emission tomography. J Neurohem 1989; 53: 311-314.
15. 11C]nomifensine and positron emission tomography, Acta Neurol Scand 1987; 76 :283.
16. Kuhar MJ, Sánchez-Roa PM, Wong DF, Dannals RF, Grigoriadis DE, Lew R, Milberger M. Dopamine transporter: biochemistry, pharmacology and imaging. Eur Neurol 1990; 30(Suppl 1): 15-20.
17. 18F]GBR 13119, a presynaptic dopamine uptake antagonist. Int J Rad Appl Instrum [A] 1988; 39: 279.
18. 18F]GBR 13119 to the brain dopamine uptake system. Life Sci 1988; 42: 1347-1353.
19. Fowler JS, Volkow ND, Wolf AP, Dewey SL, Sehlyer DJ, Maegregor RR, Hitzemann R, Logan J, Bendriem B, Gatley SJ. Mapping cocaine binding sites in human and baboon brain in vivo. Synapse 1989; 4: 371-377.
20. Yu D-W, Galley SJ, Wolf AP, MacGregor RR, Dewey SL, Fowler JS, Sehlyer DJ. Synthesis of carbon-11-labeled iodinated cocaine derivatives and their distribution in baboon brain measured using positron emission tomography. J Med Chem 1992; 35: 2178-2183.
21. Fowler JS, Volkow ND, MacGregor RR, Logan J, Dewey SL, Gatley SJ, Wolf AP, Comparative PET studies of the kinetics and distribution of cocaine and cocaethylene in baboon brain. Synapse 1992; 12: 220-227.
22. Gatley SJ, Ding Y-S, Volkow ND, Chen R, Sugano Y, Fowler JS. Binding of d-threo-[C-11]methylphenidate to the dopamine transporter in vivo: insensitivity to synaptic dopamine. Eur J Pharmcol 1995; 281: 141-149.
23. 11C]beta-CFT. Nucl Med Biol 1995; 22: 965-979.
24. 11C]beta-CIT-FE, a radioligand for quantitation of the dopamine transporter in the living brain using positron emission tomography. Synapse 1996; 22: 386-390.
25. 11C]beta-CIT-FP, a potential radioligand for quantitation of the dopamine transporter: preparation, autoradiography, metabolite studies, and positron emission tomography examinations. Nucl Med Biol 1995; 22: 905-913.
26. 11C]beta-CIT binding to monoamine transporters in the monkey and human brain. Synapse 1994; 16: 93-103.
27. 11C]beta-CIT. a cocaine analogue. Preparation, autoradiography and preliminary PET investigations. Nucl Med Biol 1993; 20: 249-255.
28. Goodman MM, Kung M-P, Kabalka GW, Kung HF, Switzer R. Synthesis and characterization of radioiodinated N-(3-iodopropen-l-yl)-2β-carbomethoxy-3β-(4-chlorophenyl) tropanes: potential dopamine reuptake site imaging agents. J Med Chem 1994; 37: 1535-1542.
29. 123I]β-CTT: pharmacological characterization of brain uptake in nonhuman primates. Synapse 1993; 13: 295-309.
30. Scheffel U, Dannals RF, Suehiro M, Ricaurte GA, Carroll FI, Kular MJ, Wagner HN Jr. Development of PET/SPECT Ligands for the serotonin transporter [review]. NIDA Res Monogr 1994; 138: 111-130.
31. Shaya EK, Scheffel U, Dannals RF, Ricaurte GA, Carroll FI, Wagner HN Jr, Kuhar Mi, Wong DF. In vivo imaging of dopamine reuptake sites in the primate brain using single photon emission computed tomography (SPECT) and iodine-123 labeled RTI-55. Synapse 1992; 10: 169-172.
32. 123I]β-CIT SPHCT. Parkinsonianism and Related Disorders 1995; 147-51.
33. Kung M-P, Essman WD, Frederick D, Meegalla S, Goodman M, Mu M, Hucki I, Kung HF. IPT: a novel iodinated ligand for the CNS dopamine transporter. Synapse 1995; 20:316-324.
34. Innis RB, Seibyl JP, Scanley BE, et al. Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson's disease. Proc Natl Acad Sci USA 1993; 90: 11965-11969.
35. Innis RB. Single photon emission tomography imaging of dopamine terminal innervation: a potential clinical tool in Parkinson's disease [editorial; review]. Eur J Nucl Med 1994; 21: 1-5.
36. Seibyl JP, Laruelle MA, Van Dyck CH, Wallace E, Baldwin RM, Zoghbi SS, Zea-Ponce Y, Neumeyer JL, Charney DS, Hoffer PB, Innis RB. Reproducibility of iodine-123-β-CIT SPECT brain measurement of dopamine transporters. J Nucl Med 1996; 37: 222-228.
37. Kuikka JT, Akerman K, Bergstrom KA, Karhu J, Hiltunen J, Haukka J, Heikkinen J, Tiihonen J, Wang S, Neumeyer JL. Iodine-123-labeled N-(2-fluoroethyl)-2β-carbomethoxy-3β-(4-iodophenyl) nortropane for dopamine transporter imaging in the living human brain. Eur J Nucl Med 1995; 22: 682-686.
38. Neumeyer JL, Wang S, Gao Y, Milius RA, Kula NS, Campbell A, Baldessarini RJ, Zea-Ponce Y, Baldwin RM, Innis RB. N-β-Fluoroalkyl analogs of (1R)-2β-carbomethoxy-3β-(4-iodophenyl)-tropane (β-CIT): radiotracers for positron emission tomography and single photon emission computed tomography imaging of dopamine transporters. J Med Chem 1994; 37: 1558-1561.
39. 123I]β-CIT binding to dopamine transporters in healthy human subjects. J Cereb Blood Flow Metab 1994; 14: 982-994.
40. Kuikka JT, Bergstrom KA, Ahonen A, Lansimies E, The dosimetry of iodine-123 labelled 2β-carbomethoxy-3β-(4-iodophenyl)tropane. Eur J Nucl Med 1994; 21: 53-56.
41. 123I]β-CIT. Binding kinetics in the human brain. J Neural Transm Gen Sect 1993; 94: 137-146.
42. Kuikka JT, Bergstrom KA, Vanninen E, Lanlumaa V, Hartikainen P, Lansimies E. Initial experience with single-photon emission tomography using iodine-123-labelled 2β-carbomethoxy-3β-(4-iodophenyl) tropane in human brain. Eur J Nucl Med 1993; 20: 783-786.
43. 123/125I]RTI-55, an in vivo label for the serotonin transporter. Synapse 1992; 11: 134-139.
44. Malison RT, Vessotskie JM, Kung M-P, McElgin W, Romaniello G, Kim H-J, Goodman MM, Kung HF. Striatal dopamine transporter imaging in nonhumun primates with iodine-123-IPT SPECT. J Nucl Med 1995; 36: 2290-2297.
45. Mozley PD, Stubbs JB, Kim H-J, McElgin W, Kung M-P. Meegalla S, Kung HF. Dosimetry of an iodine-123-labeled tropane to image dopumine transporters. J Nucl Med 1996; 37: 151-159.
46. Scanley BE, AI-Tikriti MS, Gandelman MS, Laruelle MA, Zea-Ponce Y, Baldwin RM, Zoghbi SS, Hoffer PB, Charney DS, Wang S, Neumeyer JL, Innis RB. Comparison of [I-123]β-CIT and [I-123]IPCIT as single photon emission tomography radiotracers for the dopamine transporter in nonhuman primates. Eur J Nucl Med 1995; 22: 4-11.
47. Kuikka JT, Bergstrom KA, Ahonen A, Hiltunen J, Haukka J, Lansimies E, Wang SY, Neumeyer JL, Comparison of I-123 labeled 2β-carbomethoxy-3β-(4-iodophenyl) tropane and 2β-carbomethoxy-3β-(4-iodophenyl)-N-(3- fluoropropyl) nortropane for imaging of the dopamine transporter in the living human brain. Eur J Nucl Med 1995; 22: 356-360.
48. Abi-Dargham A, Gandelman MS, DeErausquin GA, Zea-Ponce Y, Zoghbi SS, Baldwin RM, Laruelle M, Charney DS, Hoffer PB, Neumeyer JL, Innis RB. SPECT imaging of dopamine transporters in human brain with iodine-123-fluoroalkyl analogs of β-CIT. J Nucl Med 1996; 37: 1129-1133.
49. Fischman AJ, Babich JW, Elmaleh DR, Barrow SA, Meltzer P, Hanson RN, Madras BK. SPECT imaging of dopamine transporter sites in normal and MPTP-treated rhesus monkeys. J Nucl Med 1997; 38: 144-150.
50. Ishikawa T, Dhawan V, Kazumata K, Chaly T, Mandel F, Neumeyer J, Margouleff C, Babchyck B, Zanzi I, Eidelberg D, Comparative nigrostriatal dopaminergic imaging with iodine123-βCIT-FP/SPECT and fluorine-18-FDOPA/PET. J Nucl Med 1996; 37: 1760-1765.
51. 123I]IPT and single-photon emission tomography. Eur J Nucl Med 1997; 24: 415-421.
52. Asenbaum S, Brücke T, Pirker W, Podreka I, Angelberger P, Wenger S, Wober C, Muller C, Deecke L, Imaging of dopamine transporters with iodine-123-beta-CIT and SPECT in Parkinson's disease. J Nucl Med 1997; 38:1-6.
53. Hom RK, Katzenellenbogen JA. Technetium-99m-labeled receptor-specific small-molecule radiopharmaceuticals: recent developments and encouraging results [review]. Nucl Med Biol 1997; 24: 485-498.
54. Zoghbi SS, Tamagnan G, Baldwin RM, Gao Y, Neumeyer JL, Baldessarini R, Charney DS, Seibyl JP, Innis RB. Synthesis of a dopamine transporter binding cyclopentadiene phenyltropane conjugate complexed with Re and Tc-99m. J Nucl Med 1997; 38: 100P.
55. Madras BK, Jones AG, Mahmood A, Zimmerman RE, Garada B, Holman BL, Davison A, Blundell P, Meltzer PC. Technepine: a high affinity technetium-99m probe to label the dopamine transporter in brain by SPECT imaging. Synapse 1996; 22: 239-246.
56. Tamagnan G, Gao YG, Baldwin RM, Zoghbi SS, Neumeyer JL. Synthesis of β-CIT-BAT, a potential Tc-99m imaging ligand for dopamine transporter. Tetrahedron Lett 1996; 37: 4353-4356.
57. 6-(2β-carbomethoxy-3β-phenyltropane) transitional metal complexes. J Med Chem 1996; 39: 1560-1563.
58. Meltzer PC, Blundell P, Jones AG, Mahmood A, Garada B, Zimmerman RE, Davison A, Holman BL, Madras BK, A technetium-99m SPECT imaging agent which targets the dopumine transporter in primate brain. J Med Chem 1997; 40: 1835-1844.
59. Kung HF, Kim H-J, Kung M-P, Meegalla SK, Plössl K, Lee H-K. Imaging of dopamine transporters in humans with technetium-99m TRODAT-1. Eur J Nucl Med 1996; 23: 1527-1530.
60. Meegalla SK, Plössl K, Kung M-P, Stevenson DA, Liable-Sands LM, Rheingold AL, Kung HF. First example of a Tc-99m complex as a dopamine transporter imaging agent. J Am Chem Soc 1995; 117: 11037-11038.
61. Meegalla SK, Plössl K, Kung M-P, Chumpradit S, Stevenson DA, Kushner SA, McElgin WT, Mozley PD, Kung HF. Synthesis and characterization of Tc-99m labeled tropanes as dopamine transporter imaging agents. J Med Chem 1997; 40: 9-17.
62. 99mTc]TRODAT-1: a novel technetium-99m complex as a dopamine transporter imaging agent. Eur J Nucl Med 1997; 24: 372-380.
63. Moghaddam B, Bunney BS. Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat: an in vivo microdialysis study. J Neuroehem 1990; 54: 1755-1760.
64. Chrapusta SJ, Karoum F, Egan MF, Wyatt RJ. γ-Butyrolactone-sensitive and -insensitive dopamine release, and their relationship to dopamine metabolism in three rat brain regions. Eur J Pharmacol 1992; 222: 129-135.
65. 3H]WIN-35,428 to central dopamine transporters. Synapse 1996; 23:61-69.
66. Stathis M, Scheffel U, Lever SZ, Boja JW, Carroll FI, Kuhar MJ. Rate of binding of various inhibitors at the dopamine transporter in vivo. Psychopharmacology 1995; 119: 376-384.
67. 18F]WIN 35,428), a radioligand to study the dopamine transporter with PET: biodistribution in rats. Synapse 1996; 23:321-327.
68. Ritz MC, Kuhar MJ. Relationship between self-administration of amphetamine and monoamine receptors in brain: comparison with cocaine. J Pharmacol Exp Ther 1989; 248: 1010-1017.
69. Arai Y, Kim SK, Kinemuchi H, Tadano T, Satoh SE, Satoh N, Kisara K. Inhibition of brain type A monoamine oxidase and 5-hydroxytryptamine uptake by two amphetamine metabolites, p-hydroxyamphetamine and p-hydroxynorephedrine. J Neurochem 1990; 55: 403-408.
70. Amejdki-Chab N, Costentin J, Bonnet JJ, Kinetic analysis of the chloride dependence of the neuronal uptake of dopamine and effect of anions on the ability of substrates to compete with the binding of the dopamine uptake inhibitor GBR 12783. J Neurochem 1992; 58: 793-800.
71. Hume SP, Myers R, Bloomfield PM, Opacka-Juffry J, Cremer JE, Ahier RG, Luthra SK, Brooks DJ, Lammertsma AA. Quantitation of carbon-11-labeled raclopride in rat striatum using positron emission tomography. Synapse 1992; 12: 47-54.
72. Brown EE, Damsma G, Cuinming P, Fibiger HC. Interstitial 3-methoxytyramine reflects striatal dopamine release: an in vivo microdialysis study. J Neurochem 1991; 57: 701-707.
73. 2 antagonists on the transient increase of dopamine release by dopamine agonists by means of brain dialysis. Neurosci Lett 1991; 133: 77-80.